 BOSTON, Oct. 05, 2022 GLOBE NEWSWIRE -- Sensei Biotherapeutics, Inc. Nasdaq: SNSE, an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer, today announced it will present two posters at the Society for Immunotherapy of Cancer SITC 37th Annual Meeting, being held in Boston, MA from November 8 - 12, 2022. 